Document Detail


Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance.
MedLine Citation:
PMID:  17612907     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Rosiglitazone (RSG) has been reported to reduce blood pressure (BP) in patients with type-2 diabetes, but similar effects in non-diabetic people with insulin resistance is less clear. Our aim was to test the long-term BP-lowering effects of RSG compared with placebo. METHODS: We recruited participants for BP evaluation of RSG treatment from a larger intervention trial. Office BP was recorded in 355 non-diabetic subjects with insulin resistance randomized to receive either RSG or placebo for 52 weeks. Ambulatory BP monitoring (ABPM; Spacelab 90207) was performed in a subgroup of 24 subjects (RSG: n = 11; placebo n = 13). RESULTS: After 1 year, the office BP decreased by -3.1 mmHg systolic (p<0.05) and -3.8 mmHg diastolic (p<0.001) in the RSG group versus placebo. In patients treated with RSG, at 1 year there was a trend for a reduction from baseline for mean 24-h diastolic BP (DBP), daytime DBP and night-time DBP (-4.39, -5.26 and -2.93 mmHg, respectively). However, only daytime DBP was significantly lower in the RSG group compared with control (adjusted mean difference: -4.41 mmHg, p = 0.007). There was also a non-significant trend for a reduction in mean 24-h systolic BP (SBP), daytime SBP and night-time SBP (-2.70, -2.51 and -3.35 mmHg, respectively). CONCLUSIONS: RSG treatment for 1 year was associated with a small but significant decrease in diastolic 24-h ambulatory diastolic BP, and both systolic and diastolic office BPs in non-diabetic people with insulin resistance.
Authors:
Peter M Nilsson; Bo Hedblad; Jill Donaldson; Göran Berglund
Related Documents :
14564887 - Blood pressure and heart rate variability in workers of 8-hour shifts.
20500337 - The effect of crossing legs on blood pressure in hypertensive patients.
20187997 - Dietary patterns and blood pressure among middle-aged and elderly chinese men in shanghai.
11382727 - Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke...
10721957 - Hypertension, cardiovascular disease, and age-related macular degeneration. age-related...
2030547 - Clinical assessment of left ventricular systolic function by force-length and stress-sh...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Blood pressure     Volume:  16     ISSN:  0803-7051     ISO Abbreviation:  Blood Press.     Publication Date:  2007  
Date Detail:
Created Date:  2007-07-06     Completed Date:  2007-08-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9301454     Medline TA:  Blood Press     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  95-100     Citation Subset:  IM    
Affiliation:
Department of Clinical Sciences Medicine, University Hospital, Malmo, Sweden. Peter.Nilsson@med.lu.se
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Blood Pressure / drug effects*
Blood Pressure Monitoring, Ambulatory*
Diastole / drug effects
Double-Blind Method
Female
Follow-Up Studies
Heart Rate / drug effects
Humans
Hypoglycemic Agents / pharmacology*
Insulin Resistance
Male
Middle Aged
Thiazolidinediones / pharmacology*
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 0/Thiazolidinediones; 122320-73-4/rosiglitazone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential h...
Next Document:  Sleep quality among relatively younger patients with initial diagnosis of hypertension: dippers vers...